| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 148.32B | 146.67B | 140.57B | 131.91B | 125.09B | 118.88B |
| Gross Profit | 18.50B | 18.22B | 17.43B | 15.46B | 14.81B | 13.92B |
| EBITDA | 21.27B | 20.77B | 19.58B | 17.99B | 17.40B | 16.32B |
| Net Income | 9.27B | 8.93B | 8.30B | 7.40B | 7.12B | 6.43B |
Balance Sheet | ||||||
| Total Assets | 160.71B | 159.45B | 154.89B | 143.04B | 135.67B | 129.29B |
| Cash, Cash Equivalents and Short-Term Investments | 21.64B | 23.64B | 26.41B | 25.24B | 19.60B | 15.73B |
| Total Debt | 24.24B | 30.53B | 29.75B | 27.97B | 28.99B | 29.55B |
| Total Liabilities | 57.55B | 57.55B | 59.26B | 54.88B | 54.08B | 53.97B |
| Stockholders Equity | 90.77B | 89.56B | 83.94B | 77.38B | 71.56B | 66.03B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.83B | 7.67B | 11.30B | 8.11B | 4.58B |
| Operating Cash Flow | 0.00 | 14.11B | 15.88B | 13.65B | 13.60B | 11.47B |
| Investing Cash Flow | 0.00 | -11.08B | -8.30B | -3.00B | -6.03B | -7.45B |
| Financing Cash Flow | 0.00 | -5.55B | -6.50B | -5.77B | -4.19B | -4.06B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥138.07B | 11.68 | ― | 2.12% | 3.09% | 8.50% | |
68 Neutral | ¥981.46B | 10.15 | 9.97% | 3.54% | 12.46% | -3.12% | |
67 Neutral | ¥322.75B | 19.07 | ― | 2.94% | 4.50% | 82.34% | |
66 Neutral | ¥307.83B | 12.68 | 8.30% | 2.50% | 7.94% | -13.01% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
57 Neutral | ¥321.91B | 20.24 | ― | 1.28% | 8.11% | -9.27% | |
53 Neutral | ¥866.83B | 310.63 | ― | 2.99% | 4.96% | 1.67% |